GT Biopharma Inc. (NASDAQ: GTBP) started the day on April 05, 2021, with a price increase of 14.60% at $8.24. During the day, the stock rose to $8.49 and sunk to $6.65 before settling in for the price of $7.19 at the close. Taking a more long-term approach, GTBP posted a 52-week range of $2.04-$13.09.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 87.00%. This publicly-traded company’s shares outstanding now amounts to $4.51 million, simultaneously with a float of $3.94 million. The organization now has a market capitalization sitting at $200.56 million. At the time of writing, stock’s 50-day Moving Average stood at $6.41, while the 200-day Moving Average is $4.58.
GT Biopharma Inc. (GTBP) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. GT Biopharma Inc.’s current insider ownership accounts for 0.90%, in contrast to 1.50% institutional ownership.
GT Biopharma Inc. (GTBP) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
GT Biopharma Inc.’s EPS increase for this current 12-month fiscal period is 87.00% and is forecasted to reach -1.13 in the upcoming year.
GT Biopharma Inc. (NASDAQ: GTBP) Trading Performance Indicators
Let’s observe the current performance indicators for GT Biopharma Inc. (GTBP). It’s Quick Ratio in the last reported quarter now stands at 0.00. The Stock has managed to achieve an average true range (ATR) of 0.67.
In the same vein, GTBP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.49, a figure that is expected to reach -0.05 in the next quarter, and analysts are predicting that it will be -1.13 at the market close of one year from today.
Technical Analysis of GT Biopharma Inc. (GTBP)
If we take a close look at the recent performances of GT Biopharma Inc. (NASDAQ: GTBP), its last 5-days Average volume was 0.46 million that shows progress from its year to date volume of 0.37 million. During the previous 9 days, stock’s Stochastic %D was recorded 96.53% While, its Average True Range was 0.67.
Raw Stochastic average of GT Biopharma Inc. (GTBP) in the period of the previous 100 days is set at 53.98%, which indicates a major fall in contrast to 90.71% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 75.12% that was lower than 168.81% volatility it exhibited in the past 100-days period.